Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer
- 1 May 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (13), 2170-2176
- https://doi.org/10.1200/jco.2008.17.5935
Abstract
Purpose To evaluate whether diabetes affects patterns of adjuvant chemotherapy use, toxic effects of chemotherapy, and breast cancer outcomes. Patients and Methods By using the Surveillance, Epidem...Keywords
This publication has 16 references indexed in Scilit:
- Quality of Life Following Breast-Conserving Therapy or Mastectomy: Results of a 5-Year Prospective StudyThe Breast Journal, 2004
- Breast Cancer: Biological Characteristics in Postmenopausal Type 2 Diabetic Women. Identification of Therapeutic TargetsCurrent Drug Target - Immune, Endocrine & Metabolic Disorders, 2003
- Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgeryPublished by Ovid Technologies (Wolters Kluwer Health) ,2003
- Population-Based Assessment of Hospitalizations for Toxicity From Chemotherapy in Older Women With Breast CancerJournal of Clinical Oncology, 2002
- Identifying Persons with Diabetes Using Medicare Claims DataAmerican Journal of Medical Quality, 1999
- A Comprehensive Prognostic Index to Predict Survival Based on Multiple ComorbiditiesMedical Care, 1999
- Stopping Metastases at Their SourceNew England Journal of Medicine, 1997
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Validity of Certified Causes of Death in Breast Carcinoma PatientsActa Radiologica: Oncology, 1985